Identify Potential PPIs

Tackling Protein-Protein Interactions (PPIs) represents one of the most formidable frontiers in modern drug discovery, primarily because these targets typically feature expansive, shallow, and highly dynamic contact surfaces that lack the deep binding pockets favored by traditional small molecules. To conquer this previously "undruggable" landscape, LigandScout XT leverages its next-generation 3D pharmacophore modeling technology to intricately decode these massive interaction networks. Instead of being restricted to simple cavities, researchers can comprehensively map the entire PPI interface, precisely identifying the critical energetic "hotspots" — such as essential hydrophobic patches, specific pi-interactions, and crucial hydrogen bond networks — that drive the protein-protein association.

However, because a comprehensive pharmacophore model of a full PPI interface is inherently large and complex, finding a single small molecule that perfectly matches every single feature is practically impossible. This is where LigandScout’s revolutionary, ultra-fast partial mapping search algorithm becomes an absolute game-changer. Rather than demanding a rigid, 100% feature match that would inevitably result in zero hits, this highly optimized screening engine allows scientists to define flexible matching thresholds.

By screening ultra-large compound databases and requiring molecules to fulfill only a strategic subset of these critical interaction nodes (for instance, matching 8 out of 20 key interfacial features), the algorithm rapidly identifies diverse, drug-like chemotypes that can effectively anchor into the most important regions of the interface. This ultra-fast partial matching approach brilliantly bridges the gap between massive interfacial biology and small-molecule chemistry, empowering discovery teams to efficiently pinpoint highly potent molecular wedges capable of successfully disrupting or modulating challenging PPIs.

Contact us for an evaluation license of LigandScout XT !